Patients received a new treatment for heart valve disease, which did not require riskier open-heart surgery or travel to London. Five people from Cambridgeshire, Essex, Hertfordshire, Peterborough and ...

Yang noted that SAVR and TAVR on their own just put valves in without any change in annular structure. Surgeons often turn ...

There is currently no way to stop calcification of the aortic valve. If all else fails, the valve must be replaced. To better ...

NEW YORK CITY -- The newer Navitor looked increasingly viable as a transcatheter aortic valve replacement (TAVR) system, ...

The prevalence of aortic stenosis (AS) and amyloid transthyretin cardiomyopathy (ATTR‐CM) increases with age. While the global prevalence of calcific aortic valve disease is estimated to be >2% in ...

Frame design influences critical parameters such as radial strength, flexibility, fatigue resistance and conformability to ...

Objective To determine the early and long-term outcomes of conventional aortic root (ARR) and valve-sparing root replacement (VSRR) using a standard perioperative and operative approach. Methods We ...

Aortic stenosis (AS) is 1 of the most common heart valve diseases in developed countries, affecting 1 in 20 persons >65 years of age. 1 – 6 Once symptomatic, the prognosis of AS is extremely poor ...

Objective To evaluate the effect of age and aortic valve anatomy (tricuspid (TAV) vs bicuspid (BAV) aortic valve) on the relationship between the aortic valve calcification (AVC) and the haemodynamic ...

1 Introduction. Calcific aortic valve disease (CAVD) represents a significant and growing public health concern (Huang et al., 2023).Characterized by the abnormal accumulation of calcium deposits ...